Reoperations, redo surgery and other interventions constitute more than one-third of vascular surgery  by A study from Swedvasc (The Swedish Vascular Registry), 
Eur J Vasc Endovasc Surg 14, 244-251 (1997) 
Reoperations, Redo Surgery and Other Interventions Constitute More 
Than One-third of Vascular Surgery 
A study from Swedvasc (The Swedish Vascular Registry) * 
The Swedish Society for Vascular Surgeryt 
Objectives: To describe the incidence of reoperations within 30 days, later redo procedures, and other interventions after 
vascular procedures. 
Design: Analysis of vascular procedures prospectively recorded in The Swedvasc Registry. 
Materials and Methods: From 1987 to 1991, 8089 primary interventions were done for acute ischaemia, elective and 
emergency aortic aneurysms, intermittent claudication, critical leg ischaemia nd carotid artery stenosis. Subsequent 
arterial surgery was identified until the end of 1995. 
Results: Of an additional 4927 procedures, 24.1% were performed within 30 days of the first operation, 29.6% during 
the remaining first year, and 14.1%, 10.5% and 8.5% during the following 3 years, respectively. Thus, 15.5-41.5% of 
patients, depending on the indication, had further vascular surgery within a 4-year period. 
After operations for acute ischaemia or emergency aortic aneurysms, half of the reinterventions were performed within 
30 days. In claudication, critical ischaemia, nd after carotid endarterectomy, reinterventions peaked later during the first 
postoperative year. At 4 years the proportion without repeated surgery was 69%, patient survival 59% and event-free 
survival 39%. 
Conclusions: The considerable risk of reintervention after vascular procedures, and the limited life expectancy ofpatients, 
should be considered in treatment decisions for vascular disease. 
Key Words: Reoperations; Vascular surgery; Redo procedures; Event-free survival; Patient survival; Heterogeneity. 
Introduction events, and to describe the event-free and patient 
survival. 
It is well known by vascular surgeons that early re- 
operations may occur as often as in one patient in ten. 
It is also common knowledge that repeated surgery at 
a later date, either as a redo procedure or as another 
intervention, may become necessary in patients who 
have had a previous vascular procedure. 1'2 The impact 
of reoperations, both for the distribution of resources 
and in clinical decision making, have also been ad- 
dressed. 3'4 However, most available reports on the 
occurrences of these events are either limited to the 
immediate postoperative period or concern only se- 
lected procedures, s'6
The aims of this study were to describe the oc- 
currence of repeated vascular procedures for a longer 
period of time after unselected primary arterial pro- 
cedures, to identify possible risk factors for these 
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Material and Methods 
The Swedish Vascular Registry (Swedvasc) presently 
records almost all peripheral vascular procedures, in- 
cluding endovascular interventions, within the coun- 
try. The setting-up and early results of the registry has 
been previously reported. 7-9 More than 45000 pro- 
cedures have been recorded since the registry started 
in 1987. Validation against the National Board of 
Health and Welfare In-patient Registry for 1993 
showed that more than 90% of the procedures per- 
formed are included in the Swedvasc (elective an- 
eurysm 92%, emergency aneurysm 95%, embolectomy 
96%, carotid endarterectomy 96%, crural bypass 91% 
and aortofemoral bypass 93%). 
From the years 1987 to 1991, 8089 consecutive prim- 
ary arterial interventions were identified ('index pro- 
cedures'). The indications were acute ischaemia (1625), 
elective aortic aneurysm (703), emergency aneurysm 
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Table 1. Distribution of risk factors. Figures are percentages, except for age. 
Category Median Male (%) Previous Cerebro- Diabetes Hyper- 
age vascular vascular tension 
(years) surgery disease 
Cardiac Pulmon- Rena l  Smoker 
disease ary disease within 
disease last 5 
years 
Acute ischaemia 79 47.2 14.6 24.7 16.6 31.1 
Elective arteurysm 70 81.4 9.1 10.2 5.3 45.9 
Emergency 73 83 6.1 15.2 4.2 39.4 
aneurysin 
Claudication, op 67 64.5 18.1 8.0 13.1 37.6 
Claudication 66, 60.5 19.0 7.4 19.9 35.1 
Angioplasty 
Critical ischaemia 
Operation 75 51.1 23.9 14.3 32.4 39.9 
Angioplasty 77 42.4 17.5 12.9 41.8 38.2 
Carotid stenosis 67 69.7 8.9 74.7 10.4 43.8 
72.6 10.1 5.3 17.5 
41.0 14.4 9.5 53.5 
44.8 13.1 9.5 38.2 
39.3 9.1 4.2 67.6 
38.4 7.0 4.3 60.7 
52.9 10.7 6.2 40.5 
46.4 8.4 6.8 28.1 
37.3 4.6 3.5 46.5 
Table 2. Risk factors recorded at the index procedure. 
Age 
Sex 
Previous vascular procedures 
Cerebrovascular disease 
Diabetes 
Hypertension 
Heart disease 
Pulmonary disease 
Renal insufficiency 
Smoking 
In claudicants and in patients with critical ischaemia, nkle-branchial 
index and the anatomical level of reconstruction was also recorded. 
Critical ischaemia was subdivided into three groups: rest pain, 
ischaemic ulcer and gangrene. 
(505), intermittent claudication (1910), critical leg isch- 
aemia (2828) and carotid artery stenosis (518). Pro- 
cedures for claudication were endovascular in 37.5% 
(717), as were 22.8% (644) of procedures for critical 
ischaemia. 
Repeated vascular surgery in these patients was 
identified in the registry until the end of 1995 and 
classified into three categories. Reoperations within 30 
days (REOP30) included reoperations for occlusion 
and for bleeding, as well as some redo procedures, 
but no other site interventions. Redo procedures were 
reoperati'ons later than 30 days (REDO) on the same 
anatomical site as the index procedure. Other site 
interventions (OSI) were performed in the same patient 
but on another anatomical site. Thus, all patients were 
fo l lowed for at least 4 years. A total number  of 4927 
reinterventions were identified. The presentation of 
data in text and figures is l imited to the first 4 years 
after the index procedure, if not otherwise stated. 
Mortality data were obtained from the National Popu- 
lation Registry. 
Risk factors present at the index procedure and as 
recorded by the surgeon are shown in Table 1 for the 
different patient categories. These risk factors (Table 
2) were related to the occurrence of the different 
types of subsequent procedures by logistic regression, 
Survival curves according to Kaplan-Meier were cal- 
culated to illustrate patient and event-free survival. 
Data management  and calculations were performed 
using the various modules of the SPSS for Windows 
programme package, version 6.1. 
Results 
Two distinct patterns of the time distribution of re- 
peated surgery for the different patient categories were 
found. After operations for acute ischaemia nd aortic 
aneurysms, around half of reinterventions were per- 
formed within 30 days. After procedures for clau- 
dication, critical leg ischaemia and carotid artery 
stenosis, repeated surgery peaked later during the first 
postoperative year (Figure 1[a-hi). The differences 
in distribution between the three types of repeated 
surgery is seen in Table 3. Early reoperations dominate 
after surgery for acute ischaemia, while aneurysm 
procedures also are followed by a considerable pro- 
portion of other site interventions. Chronic leg isch- 
aemia has a uniform pattern both for claudication and 
critical ischaemia, except the low proport ion of early 
reoperations after angioplasty. Carotid surgery 
demonstrates a fourth pattern, with a dominance of 
other site interventions. 
Preoperatively-registered isk factors according to 
Table 2 that were significantly related to repeated 
surgery by logistic regression analysis are shown in 
Table 4 for the different patient categories. No con- 
sistent pattern is seen. Over time, the proport ion of 
patients treated for chronic leg ischaemia who can 
avoid repeated vascular surgery diminishes. Figure 
2 (a-h) also show Kaplan-Meier curves for patient 
survival and the combined event-free survival. After 
4 years the probabil ity of being alive without repeated 
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Fig. 1. (a-h). Distribution over time for repeated vascular su gery m the eight patient categories. 
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Table 3. Percentages of repeated vascular surgery of the primary 
procedures. 
Category n REOP30 REDO OSI 
(%) (%) (%) 
Acute ischaemia 1625 19.0 7.8 7.5 
Leg 1402 19.5 8.3 8.5 
Arm 223 16.1 4.0 4.0 
Elective aortic aneurysm 703 6.4 2.0 7.8 
Emergency aortic 
aneurysm 505 11.7 2.0 7.1 
Claudication, operation 1193 7.0 13.7 17.3 
Claudication, angioplasty 717 4.2 11.6 13.9 
Critical ischaemia, 
operation 2184 11.4 12.4 16.3 
Critical ischaemia, 
angioplasty 644 3.4 9.8 9.5 
Carotid stenosis 518 6.9 1.7 19.7 
All procedures 8089 10.3 9.1 12.9 
(REOP30 = reoperation within 30 days; REDO = redo surgery later 
than 30 days after the primary operation; OSI = other site inter- 
vention). 
surgery varies from 21-64%, depending on category 
of index procedure. 
Acute ischaemia 
Previous surgery features as a risk factor for repeated 
interventions. Age is a significant negative factor; both 
early reoperations and OSI decrease with increasing 
age. The curve of relatively few reinterventions i  
combined with the steeper slope of patient survival 
into an event-free survival of 21% at 4 years. 
Aortic aneurysm 
No significant risk factors for early reoperations or 
redo surgery after aneurysm repair were found. After 
elective operation only the presence of smoking was 
significantly related to OSI, as was hypertension after 
emergency operation. The survival curves are dom- 
inated by the early mortality after emergency op- 
erations. 
Intermittent claudication 
Previous surgery was a risk factor for redo surgery 
and OSI after operation, but only for OSI after an- 
gioplasty for this indication. Diabetes and hyper- 
tension also increased the risk for OSI in these patients. 
Redo surgery was more common after distal re- 
constructions. Claudicants had a 4-year event-flee sur- 
vival of around 50%. 
Critical leg ischaemia 
After surgery for CLI, women had an increased risk 
for early reoperations, as had diabetics, patients with 
cardiac disease and patients treated above the groin 
level after angioplasty. Redo surgery was more com- 
mon after procedures below the knee and in patients 
with rest pain as opposed to tissue loss. With increasing 
age fewer patients had redo procedures after surgery 
and fewer OSI's both after surgery and angioplasty. 
The survival curves demonstrate the effects of active 
repeated surgery during the years after the index 
procedure, which combines with the patient mortality 
into the steep event-free survival curve with its 4-year 
value of close to 25%. 
Carotid stenosis 
No risk factors for early reoperative or redo surgery 
after carotid endoarterectomy were found. Renal dis- 
ease and smoking were significantly related to an 
increased risk of OSI. The event-free survival for these 
patients exceeded 60% at 4 years. 
Discussion 
These 8089 primary vascular procedures were fol- 
lowed by 4927 repeated procedures during the fol- 
lowing 4-9 years. Data recently obtained from the 
National In-patient Registry, but not yet fully analysed, 
has revealed that the individuals in this study ex- 
perienced another 6834 episodes of hospital stay with 
an operative procedure not recorded in the vascular 
registry, and 42 276 episodes of hospital stay without 
surgery, during the 1987-1994 period. Not surprisingly, 
the considerable risk for repeated vascular intervention 
after one primary reconstructive procedure differed 
in its expression among the patient categories. It is 
known from recent data from a centre with a special 
interest in vascular surgery 1°-12 that the occurrence of 
repeated surgery after vascular procedures may be 
significant; however, this is the first report of na- 
tionwide long-term follow-up data. 
Practice might change over time, and we have found 
in a previous study that a significant decrease in the 
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Table 4(a). Statistically significant risk factors for repeated vascular surgery after surgery for acute ischaemia, aneurysm and carotid 
stenosis as identified by logistic regression analysis. 
Category REOP30 RR (95% CI) REDO RR (95% CI) OSI RR (95% CI) 
Acute ischaemia Previous 1.42 (1.02-1.99) Previous 1.85 (1.19-2.88) Age -3%)year 
surgery surgery 
Age --2%/year Smoking 1.97 (1.24-3.14) Previous 1.95 (1.26-2.99) 
surgery 
Smoking 1.91 (1.20-3.04) 
Elective aortic None None Smoking 1.90 (1,04-3.48) 
aneurysm 
Emergency None None Hypertension 2.44 (1.19-4.98) 
aortic 
aneurysm 
(RR = relative risk and confidence interval of 95%). 
Table 4(b). Statistically significant risk factors for repeated vascular surgery after surgery for chronic leg ischaemia as identified by 
logistic regression analysis. 
Category REOP30 RR (95% CI) REDO RR (95% CI) OSI RR (95% CI) 
Claudication None Previous 1.85 (1.24-2.77) Previous 2.05 (1.44-2.93) 
Surgery surgery surgery 
Above groin vs 0.38 (0.28-0.49) 
BK 
Thigh vs BK 1.53 (1.22-1.93) 
Above groin vs 0.65 (0.42-0.98) 
BK 
Claudication Pulmonary 3.95 (1.16-13.39) Previous 2.31 (1.40-3.81) 
Angioplasty disease surgery 
Diabetes 1.90 (1.15-3.14) 
Hypertension 1.68 (1.06-2.66) 
Critical Female sex 1.41 (1.06-1.88) Age -3%/year Age -4%/year 
ischaemia 
surgery Diabetes 0.74 (0.54-0.99) Cerebrovasc 0.52 (0.35-0.78) 
Above groin 0.60 (0.45-0.82) 
vs BK 
Rest pain vs 1.26 (1.05-1.53) 
gangrene 
Critical Diabetes 2.80 (1.06-7.39 Above groin vs 0.50 (0.28-0.89) Age -5%/year 
ischaemia BK 
angioplasty Cardiac disease 2.98 (1.08-8.25) Rest pain vs 2.26 (1.30-3.95) 
gangrene 
Above groin 2.23 (1.09-4.54) 
vs BK 
Carotid stenosis None None Renal disease 3.55 (1.30-9.73) 
Smoking 1.59 (1.01-2.53) 
proport ion of patients operated on for acute ischaemia 
coincided with an increase in the proport ion of elective 
procedures for critical ischaemia during the period 
1987-91. 9 In this study there was a decrease in the 
incidence of early reoperations after acute ischaemia 
over time that did not reach statistical significance, 
which, on the other hand, the decrease in redo pro- 
cedures did. There was no change in OSI after op- 
erations for acute ischaemia. It seems vascular 
surgeons change their practice over time, even in the 
short 5-year perspective. The multivariate analysis 
showed that significant risk factors for the different 
types of repeated surgery were few, and they did not 
show any consistent pattern. The patient categories 
differ, and it is therefore not surprising that no simple 
explanation was found for the necessity for repeated 
interventions. The variables were recorded by in- 
dividual surgeons, and perhaps with various degrees 
of attention and interest. They are rather crudely de- 
fined and their validity might be questioned. Several 
of the significant risk factors imply a more severe 
degree of vascular disease, which makes repeated 
surgery understandable and reasonable. On the other 
hand, it also makes sense that increasing age, cerebro- 
vascular disease, diabetes and distal disease are related 
to fewer repeated procedures in critical leg ischaemia. 
Sometimes urgeons obviously accept hat 'enough is 
enough'. 
The time patients can enjoy in good health after a 
successful reconstruction is of great importance to the 
individual. It is worrying that so many of the vascular 
patients either need repeated vascular interventions 
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Fig. 2. (a-h). Survival curves according to Kaplan-Meier for the eight patient categories, howing proportion without repeated surgery 
(thin line), patient survival (broken medium line) and the combination of these two into the event-free survival (heavy line). 
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or die within a relatively short period after their 
primary procedure. One important task for future 
research, therefore, is to analyse quality of life during 
the event-free period compared to no primary inter- 
vention at all. The palliative nature of vascular surgery, 
not always realized, is also demonstrated in that one- 
third of procedures are different types of re- 
interventions. Similar proportions have been reported 
from Finland. 13 
In clinical research the randomised trial is generally 
considered the gold standard technique in evaluation 
of the cause-effect relationship or in the comparison 
between different treatment alternatives. However, 
many issues are not easily studied this way, for a 
number of reasons. Among these are financial re- 
strictions, need for long-time follow-up, or difficulties 
in recruiting a sufficient number of patients. Ob- 
servational studies, on the other hand, can sometimes 
make up for these difficulties and remain important 
to generate hypotheses in the study of very rare phe- 
nomena or differences between practitioners or in- 
stitutions. Several authors have discussed conditions 
for observational studies to give reliable and gen- 
eralisable bias. Continuous comparison with national 
databases accomplishes this for Swedvasc. Thus, we 
consider the data in this study representative of routine 
surgical care, and consequently our conclusions to 
some extent may be valid also outside of Swedvasc. 
Vascular surgeons tend to look at their patients as 
belonging to homogenous groups concerning in- 
dication, sometimes even as 'type-operation' groups. 
Reporting results of a specific type of procedure with- 
out stratifying for degree or type of disease is not 
uncommon, but neglects the fact that patients differ 
in many prognostically important aspects. It is likely 
that better characterisation of patients would mean 
better treatment decisions, either in the choice of active 
treatment or in abstention of probably futile pro- 
cedures. Our data indicate that it indeed may be 
possible ~to identify prognostically important sub- 
groups within seemingly homogenous patient groups. 
In the vascular field this concept of heterogeneity has 
been demonstrated in a number of settings. 18-2° This 
may very well be the way to tailor treatment better to 
individual patients, improve outcomes and reduce the 
need for repeated surgery. 
In conclusion, vascular patients have frequent re- 
peated vascular interventions occurring in different 
patterns and with different risk factors and sometimes 
with a limited event-free survival. The surgical pro- 
fession ought to consider this phenomenon and de- 
velop standards for acceptable l vels of these events 
in different patient categories. Further esearch should 
aim at identifying prognostically important subgroups 
among the vascular patients, with a view to improved 
patient selection. 
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